Search Results 961-970 of 17141 for peptide stacks
About this study. The objective of the program is to provide access to TAS-102 to patients with metastatic colorectal cancer who are refractory to or ...
About this study. The purpose of this study is to collect peripheral blood samples and urine samples from patients with plasma cell disorders for metabolite ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Marla Broadfoot, Ph.D. April 6, 2026. Mayo Clinic experimental dual-drug nanotherapy crosses the blood-brain barrier and improved survival.
There is evidence that colonic inflammation plays a major role in colon polyp and colorectal cancer development. For example, inflammatory bowel disease is a ...
About this study. This first-in-human (FIH) dose-escalation and dose-validation/expansion study will assess KO-2806, a farnesyl transferase inhibitor (FTI), ...
Learn about the types of tumors that make up this group of rare cancers. Find out about symptoms, causes, diagnosis and treatments.
Levels of bladder cancer-derived extracellular vesicles become undetectable after radical cystectomy in patients with localized bladder cancer. This study hopes ...
The purpose of this study is to assess DNA markers in pancreatic juice and stool for the detection of pancreatic cancer and precancer. Participation eligibility.
The purpose of this study is to assess the integrated effect of normalization of intestinal dysbiosis through a structured semi-vegetarian dietary intervention ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!